Home › Trials › NCT06675903
Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring glucose levels after kidney transplantation

Official title: Continuous Glucose Monitoring in Kidney Transplant Recipients With Diabetes, Pre-diabetes and Without Diabetes

Run by Copenhagen University Hospital, Rigshospitalet · NCT06675903 · Data updated 2026-11-12

This study looks at how glucose levels change in kidney transplant patients during the first two weeks after surgery to see if there are differences between those with diabetes, prediabetes, and no diabetes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment54 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Drugs / interventionsprednisone
Locations1 site (Copenhagen, DK)
StatusRecruiting
StartedNovember 12, 2024
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedAugust 18, 2026
Trial IDNCT06675903 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are undergoing kidney transplantation and have varying glucose regulation statuses.

Probably not a fit

Patients who are unable to cooperate with CGM monitoring in the first ten days post-surgery or those with combined organ transplants may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates glucose levels in kidney transplant recipients using continuous glucose monitoring (CGM) within the first two weeks post-surgery. It focuses on three groups: patients with diabetes, prediabetes, and those without diabetes, analyzing differences in their glucose profiles. The study aims to understand how hyperglycaemia develops in these patients, particularly in relation to immunosuppression and steroid use. A total of 54 participants will be monitored to assess glucose indices and adherence to treatment guidelines.

Why it matters

Potential benefit: If successful, this study could lead to improved management of glucose levels in kidney transplant recipients, potentially reducing the risk of post-transplant diabetes and related complications.

How similar studies have gone: While there have been minor studies using CGM in similar contexts, this specific approach to monitoring glucose post-kidney transplantation is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Written informed consent obtained before CGM application
* Male or female; age: ≥18 years
* Kidney transplantation

Exclusion Criteria:

* Unable to cooperate to CGM the first ten days after surgery
* Allergic to plasters in CGM units
* Combined kidney and liver or pancreatic transplantation
* Graft loss/rejection within first 48 hours after transplantation

Where it's running

  • Rigshospitalet
    Copenhagen, Dk, Denmark     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Hyperglycaemia 2Kidney Transplantation 104Copenhagen University Hospital, Rigshospitalet 160
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.